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OBJECTIVE AND RATIONALE: This review outlines the role of the EGF network during oocyte development and regulation of the ovulatory cascade, and in particular focuses on the effect of the EGF network on oocyte developmental competence. Application of this new knowledge to advances in ART is examined.
SEARCH METHODS: The PubMed database was used to search for peer-reviewed original and review articles concerning the EGF network. Publications offering a comprehensive description of the role of the EGF network in follicle and oocyte development were used.
OUTCOMES: It is now clear that acute upregulation of the EGF network is an essential component of the ovulatory cascade as it transmits the LH signal from the periphery of the follicle to the cumulus-oocyte complex (COC). More recent findings have elucidated new roles for the EGF network in the regulation of oocyte development. EGF signalling downregulates the somatic signal 3′5′-cyclic guanine monophosphate that suppresses oocyte meiotic maturation and simultaneously provides meiotic inducing signals. The EGF network also controls translation of maternal transcripts in the quiescent oocyte, a process that is integral to oocyte competence. As a means of restricting the ovulatory signal to the Graffian follicle, most COCs in the ovary are unresponsive to EGF-ligands. Recent studies have revealed that development of a functional EGF signalling network in cumulus cells requires dual endocrine (FSH) and oocyte paracrine cues (growth differentiation factor 9 and bone morphogenetic protein 15), and this occurs progressively in COCs during the last stages of folliculogenesis. Hence, a new concept to emerge is that cumulus cell acquisition of EGF receptor responsiveness represents a developmental hallmark in folliculogenesis, analogous to FSH-induction of LH receptor signalling in mural granulosa cells. Likewise, this event represents a major milestone in the oocyte's developmental progression and acquisition of developmental competence. It is now clear that EGF signalling is perturbed in COCs matured in vitro. This has inspired novel concepts in IVM systems to ameliorate this perturbation, resulting in improved oocyte developmental competence.
Introduction
Ovulation and the concomitant final phase of oocyte development are complex biological processes that are the foundation of subsequent embryo and offspring health (Lane et al., 2014) . Healthy oocyte development is central to female fertility and oocyte quality is a key rate-limiting factor in the modern practice of ART, such as IVF. Superovulation with exogenous FSH and artificially inducing oocyte meiotic maturation using hCG or agonist triggers is a cornerstone of most ART practices and so understanding the natural processes of ovulation and oocyte developmental competence is vitally important to understanding the potential impact of these interventions on health outcomes.
Oocyte growth, maturation and ovulation are complex and intertwined processes that are initiated by endocrine cues and regulated by the ovarian follicular environment in which the oocyte is housed. Oocytes with the capacity for ovulation reside in large antral follicles predominantly comprising two granulosa cell subtypes: mural granulosa cells and granulosa-derived cumulus cells. These granulosa cells play a supporting role in the development of the oocyte by providing it with essential metabolites and mediating regulatory signals (SuttonMcDowall et al., 2010) . Ovulation is initiated by a surge in the pituitary gonadotrophin LH, which acts directly on the theca and mural granulosa cells of the follicle to induce the final stages of oocyte cytoplasmic and nuclear maturation, and subsequent follicle rupture and corpus luteum formation (Russell and Robker, 2007) . Since the preovulatory oocyte does not express the LH receptor, and its surrounding cumulus cells express very few relative to granulosa cells (Lawrence et al., 1980) , the relay and propagation of the LH stimulus throughout the follicle to the oocyte is mediated by secondary molecules, the identity and function of which have been an active area of research over the last two decades.
The epidermal growth factor (EGF) family comprises 11 proteins, including EGF, heparin-binding EGF-like growth factor (HB-EGF), transforming growth factor-α (TGFα), epigen (EPGN), the neuregulins 1-4 (NRG1-4), amphiregulin (AREG), epiregulin (EREG) and betacellulin (BTC), all of which have highly similar structural and functional properties (Schneider and Wolf, 2009) . EGF, the founding member of the EGF-family of ligands, was for many years believed to mediate the LH signal as it induced oocyte maturation and cumulus expansion in vitro in several mammalian species including human (Dekel and Sherizly, 1985; Das et al., 1992; Goud et al., 1998; Rieger et al., 1998; Prochazka et al., 2000; Su et al., 2002) . However, this hypothesis never gained traction as EGF was not immunolocalized in human preovulatory follicles (Reeka et al., 1998) , and was not found to be locally produced and secreted into the follicular fluid of preovulatory follicles following gonadotrophin stimulation for fertility treatment (Westergaard and Andersen, 1989; Reeka et al., 1998) . A seminal in vivo mouse study by Conti et al. identified three other members of the EGF-family ligands, the EGF-like peptides AREG, EREG and BTC, as critical propagators of the LH signal in the preovulatory follicle ( Fig. 1) (Park et al., 2004) . Recent studies have not only implicated EGF-like peptide signalling in granulosa and cumulus cells critical for oocyte meiotic maturation, but also have provided insight into how this signalling network co-ordinates oocyte cytoplasmic maturation and thus influences the developmental capacity of the oocyte. Furthermore, recent evidence suggests that this signalling network can be perturbed in follicles from women with polycystic ovary syndrome (PCOS) (Ambekar et al., 2015) and by various ART, for example oocyte IVM.
The objectives of this review are to provide a brief overview of the EGF-like network as the key mediator of LH in inducing ovulation, a topic which has been summarized elsewhere in excellent reviews (Downs, 2010; Conti et al., 2012) , and to examine in some detail the more recent perspectives on the participation of this signalling axis on the development of the oocyte during the antral phase of folliculogenesis and its impact on the acquisition of oocyte developmental competence. A better understanding of this signalling pathway during oocyte development and maturation is important to understand the impact of varying ART strategies on oocyte quality and subsequent embryo and offspring health.
Methods
The PubMed database was used to search for peer-reviewed original and review articles concerning the EGF network in the ovarian follicle and other cell systems. Searches were performed adopting 'amphiregulin', 'epiregulin', 'betacellulin', 'EGFR', 'oocyte', and 'cumulus cell', 'granulosa cell', 'ovulation' and 'IVM' as main terms. The most relevant publications offering a comprehensive description of the role of the EGF network in follicle and oocyte development were used. Searches were performed between January 2016 and June 2017.
Results

EGF-like peptides transmit the LH signal in the follicle
LH elicits major changes throughout the preovulatory follicle principally by reprogramming gene expression of the theca and mural granulosa cells, consequently altering first the spatial architecture and hence inter-cellular communication within the cumulus-oocyte complex (COC) (Albertini et al., 2001) , and second the cumulus cell and oocyte secretome (Eppig, 1991; Ritter et al., 2015) . Although profoundly affected by LH, the preovulatory oocyte does not express the LH receptor (Lawrence et al., 1980; Peng et al., 1991) , and although its surrounding cumulus cells have been reported to contain LH receptors, functional LH signalling is markedly lower than that on granulosa cells (Lawrence et al., 1980) . Hence for the LH signal to reach the oocyte it must be transmitted across the follicle via paracrine signals and gap junction-mediated exchange of small nucleotides . LH interacts with the LH receptor, a G protein-coupled receptor, on mural granulosa cells to activate adenylate cyclase, resulting in the marked and acute production of 3′,5′-cyclic adenosine monophosphate (cAMP), the primary LH second messenger within the follicle (Conti et al., 2002) . Cyclic AMP upregulates expression of members of the EGF-family ligands by activating a p38MAPK-CREB (PKA-p38 mitogen-activated protein kinase (MAPK)-cAMP response element-binding protein) dependent pathway (Richards, 2001; Shimada et al., 2006) . The EGF family of growth factors comprises 13 polypeptide proteins which signal through members of the ErbB family receptors (Citri and Yarden, 2006 ). An essential element of the paracrine component of the LH ovulatory signal is the production of three of these EGF-like peptides; AREG, EREG and BTC, that induce a large network of gene activation in mural granulosa and cumulus cells that co-ordinate processes including oocyte maturation, cumulus expansion, and ovulation (Park et al., 2004) . Areg or Ereg knockout mice have decreased oocyte meiotic resumption, cumulus expansion, ovulation, and 2-cell embryo rates (Hsieh et al., 2007; Kim et al., 2011; Chen et al., 2013) . Interestingly, single peptide knockout mice still yielded live offspring, indicating redundancy between the EGFlike peptides leading to activation of the EGF receptor (EGFR). These peptides are produced in many mammalian species in response to LH including mouse, rat, monkey, horse, pig and human, suggesting that this network is conserved (Freimann et al., 2004; Park et al., 2004; Sekiguchi et al., 2004; Fru et al., 2007; Chen et al., 2008; Lindbloom et al., 2008; Inoue et al., 2009; Zamah et al., 2010; Peluffo et al., 2012) .
AREG, EREG and BTC are produced as inactive transmembrane proteins comprising a signal sequence, a transmembrane domain and an extracellular EGF domain (Schneider and Wolf, 2009 ). As such, the EGF-like peptides are initially tethered to the outer plasma membrane of granulosa cells and are then proteolytically cleaved at the ectodomain by the ectoprotease, a disintegrin and metalloprotease 17 (ADAM17), also known as TACE, to release the soluble Figure 1 The EGF network transmits the LH signal from the somatic cells of the follicle to the oocyte to promote oocyte meiotic resumption and ovulation. The ovulatory LH surge simultaneously leads to an acute upregulation (shown in black) of the epidermal growth factor (EGF) signalling network in mural granulosa cells, which is then transmitted to the cumulus cells, leading to initiation of mural granulosa cell luteinisation, closure of gap junctions and production of an extensive extracellular matrix by cumulus cells; and downregulation of the meiotic inhibitory signalling network mediated by C-type natriuretic peptide (CNP) and cyclic guanosine monophosphate (cGMP) in mural granulosa and cumulus cells, leading to oocyte meiotic maturation (red denotes signals downregulated in response to the LH surge; dashed line indicates reduced cGMP diffusion in response to LH). Adapted from Gilchrist (2011). extracellular EGF domain (Dong et al., 1999; Sahin et al., 2004) . TACE/ADAM17 protein and activity is upregulated in COCs by LH and FSH (Yamashita et al., 2007) . Activation of the EGFR and its downstream targets in cumulus cells requires TACE/ADAM17 activity since its inhibition using metalloprotease inhibitors or siRNA impedes LH-induced oocyte maturation and cumulus expansion, but can be reversed by the addition of EGF to COC culture systems (Ashkenazi et al., 2005; Yamashita et al., 2007; Panigone et al., 2008) . Hence, TACE/ADAM17 activity plays an important regulatory role by controlling EGF-like peptide signalling. It is worth noting, however, that several EGFR ligands including AREG and BTC are biologically active even when tethered to the plasma membrane, indicating that they likely signal in a juxtacrine manner; however, the biological consequence of juxtacrine EGFR activation likely differs to that of autocrine/paracrine activation (Singh and Harris, 2005) .
Spatially, EGF-like peptides are first produced in the mural granulosa cells of the follicle in response to LH (Conti et al., 2006) . Following proteolytic shedding into the antral fluid, these ligands bind EGFR on mural granulosa and cumulus cells in an autocrine and paracrine manner, respectively. EGFR activation on cumulus cells stimulates autocrine production of EGF-like peptides to amplify the signal in these cells and deliver and mediate the LH stimulus from the periphery to the oocyte (Yarden and Sliwkowski, 2001; Holbro and Hynes, 2004) . LH-induced production of prostaglandin E 2 (PGE 2 ) in mural granulosa cells is required for the amplification and subsequent paracrine relay of the EGF signal from the mural to cumulus cells. PGE 2 upregulates production of the EGF-like peptides in both granulosa subtypes via a p38 MAPK dependent pathway (Shimada et al., 2006) . EGFR activation is required for oocyte meiotic resumption (Reizel et al., 2010) , however oocytes are not directly responsive to EGF-like peptides suggesting that they do not notably express EGFR (Park et al., 2004; Conti et al., 2006) . Hence, the LH/EGF-peptide ovulatory signal is transmitted to the oocyte via the EGFR on cumulus cells. Production of EGF-like peptides in the granulosa and cumulus cells is transient throughout the periovulatory period. AREG, EREG and BTC are not detectable prior to the LH surge, but are acutely upregulated to maximal levels prior to oocyte germinal vesicle breakdown (GVBD), and decline rapidly thereafter to basal levels (Conti et al., 2006) . Part of the function of the EGF network is to induce cumulus expansion, a process by which cumulus cells secrete and assemble a hyaluronic acid-rich matrix that facilitates ovulation, sperm penetration and fertilization (Salustri et al., 1996) . EGF-like peptides induce temporal mRNA expression of genes required for cumulus matrix formation (Has2, Ptx3, Tnfaip6, Ptgs2) in vitro in cumulus cells and preovulatory follicles (Ashkenazi et al., 2005; Shimada et al., 2006) , which facilitates cumulus expansion.
Granulosa and cumulus cell EGFR signalling
EGFR (also known as ErbB1, and HER1 in humans) is a transmembrane receptor tyrosine kinase (RTK). It is one of four members of the ErbB family of RTKs (ErbB1-4) comprising a ligand-binding extracellular domain, a single membrane-spanning region and an intracellular tyrosine kinase domain (Herbst, 2004) . EGFR activity is essential for oocyte maturation, cumulus expansion and ovulation as the inducing effects of LH and growth factors are blocked by pharmalogical inhibitors and genetic disruption to the EGF network (Park et al., 2004; Ashkenazi et al., 2005; Hsieh et al., 2007) . An Egfr-null mutation is embryonically lethal (Sibilia and Wagner, 1995) ; a hypomorphic Egfr mutation resulting in decreased signalling yields live offspring, however offspring reproductive potential is greatly perturbed as LH-induced oocyte meiotic resumption and cumulus expansion is significantly reduced in preovulatory follicles, leading to decreased ovulation. AREG, EREG and BTC all signal by binding and activating EGFR, however EREG and BTC can also bind and activate ErbB4 (another member of the ErbB RTK family; Table I ) with low affinity (Citri and Yarden, 2006) . Upon ligand binding, EGFR forms homodimers but can also form three functional heterodimers with other ErbB kinases (Citri and Yarden, 2006) . The specific dimer type formed determines activation of intracellular pathways as it dictates phosphorylation on specific tyrosine residues within the cytoplasmic tail that serve as docking sites for a range of ligands (Singh and Harris, 2005) .
All four ErbB kinases (EGFR, ErbB2, ErbB3 and ErbB4) have been detected in the ovary. Human preovulatory follicle granulosa and cumulus cells express these transcripts following hCG stimulation (Zamah et al., 2010; Conti, 2013) . In the mouse, EGFR, ErbB2 and ErbB3 are constutively expressed in the ovary pre-and post-hCG, and are localized to the granulosa and cumulus cells. Like EGFR, ErbB2 and ErbB3 phosphorylation occurs in response to hCG and act in the form of an ErbB3:ErbB2 heterodimer (Noma et al., 2011) . Given that ErbB2 has no known ligand, investigation into the involvement of ErbB3 ligands in the ovulation process demonstrated participation of another EGF family member, neuregulin one Type III (NRG1 ; Table I acceleration of EGF-like peptide activation of the ovulatory cascade by enhancing downstream extracellular signal-regulated kinase 1 and 2 (ERK1/2) activity and suppressing calcium levels to prevent hyperactivity of protein kinase C (Noma et al., 2011) . EGF-like peptide activation of EGFR promotes several signalling pathways including MAP kinase (MAPK), phosphatidylinositol-3 kinase (PI3K) and Janus kinase/signal transducers and activators of transcription (JAK/STAT) pathways (Rawlings et al., 2004; Oda et al., 2005; Engelman, 2009 ). PI3K pathway activation in cumulus cells plays a role in gonadotrophin stimulation of meiotic resumption (Shimada et al., 2003) . The fundamental role of ERK1/2 (also known as MAPK3/1) in mediating the ovulatory stimulus in the periovular follicle has been extensively documented (Fan et al., 2009; Shimada et al., 2016) . Activation of EGFR-ERK1/2 dependent gene transcription is responsible for the cascade of PGE 2 and p38MAPK induction that in turn upregulates production of the EGF-like peptides in cumulus and granulosa cells. This activates and maintains the EGF network throughout the follicle in order to mediate meiotic resumption and ovulation, cumulus expansion and granulosa cell luteinisation (Park et al., 2004; Ashkenazi et al., 2005; Shimada et al., 2006; Downs and Chen, 2008) (Fig. 2 ).
Ligand-EGFR interaction
Variable biological outcomes elicited by the different EGF family ligands are likely due to differential interaction with EGFR and potentially other ErbB receptors. EGFR interacts with its seven ligands (Singh and Harris, 2005) (Table I) . These ligands exhibit varying affinities to EGFR, with EGF, BTC, TGFα and HB-EGF exhibiting high affinity, and AREG, EREG and EPGN exhibiting low affinity (Singh et al., 2016) . In non-ovarian cells, AREG has been shown to stimulate greater intrinsic EGFR activity than EGF and BTC as it promotes receptor recycling and consequent increased signal duration, while BTC and EGF shorten signal duration and receptor availability by promoting receptor degradation through the pattern of tyrosine phosphorylation they induce (Gilmore et al., 2008; Roepstorff et al., 2008 Roepstorff et al., , 2009 Wilson et al., 2009) . In COCs cultured in vitro, EGF promotes a large and rapid increase in EGFR Tyr 1068 phosphorylation within 30 min of culture, followed by decreased phosphorylation from 2-12 h when compared with FSH or COCs matured in vivo . Signal duration promoted by AREG and EREG is also longer than EGF in cultured COCs (Richani et al., 2014a,b) . Interestingly, despite the differences in EGFR activity, no significant difference in activity of the downstream effector ERK1/2 is observed in response to FSH, EGF, AREG or EREG in vitro, or hCG in vivo (Richani et al., , 2014a , suggesting that other downstream targets of EGFR may be differentially altered.
Participation of the EGF network in oocyte maturation
Activation of the EGF network has long been implicated in the regulation of oocyte meiotic maturation. In the antral follicle, the somatic compartment keeps the oocyte meiotically arrested at prophase I by supplying it with the cyclic nucleotides, cAMP and 3′5′-cyclic guanine monophosphate (cGMP), through a large network of gap junctions (reviewed by Conti et al. (2012) and (Downs, 2010) ). Activity of these cyclic nucleotides is essential for maintaining oocyte meiotic arrest from the early antral follicle stage onwards. It is well established that cAMP maintains meiotic arrest by inducing oocyte PKAdependent phosphorylation of cyclin-dependent kinase 1 to suppress activity of the meiosis-promoting factor (MPF) (reviewed by Downs (2010)). The oocyte maintains sufficient cAMP levels through autonomous production via a G-protein coupled receptor with adenylate cyclase activity and from cAMP supplied from the cumulus cells via gap junctions (recently reviewed; ). In addition, recent mouse studies have shown cGMP as a regulator of intraoocyte cAMP levels ( Fig. 1) . Cyclic GMP inhibits cAMP degradation though the suppression of oocyte phosphodiesterase 3A (PDE3A) activity, a cAMP hydrolyzing enzyme (Norris et al., 2009; Vaccari et al., 2009) . Cyclic GMP is produced in the granulosa and cumulus cells via the activity of the guanylate cyclase natriuretic peptide receptor 2 (NPR2) and supplied to the oocyte through gap junctions to maintain meiotic arrest (Tornell et al., 1991; Norris et al., 2009; Vaccari et al., 2009; Zhang et al., 2010) . The LH surge causes rapid inactivation of NPR2 and coincident activation of the cGMP phosphodiesterase PDE5 within granulosa cells, which lead to the decrease in cGMP supply to the oocyte. This decrease in granulosa cGMP concentration promotes diffusion of cGMP from the oocyte and cumulus Figure 2 Schematic showing the major signalling pathways activated in granulosa and cumulus cells by the EGF-like peptides in response to the LH surge. LH induces production of the EGF-like peptides; Amphiregulin (AREG), epiregulin (EREG), betacellulin (BTC) and neuregulin 1 (NRG1) in mural granulosa cells and cumulus cells. AREG, EREG and BTC activate the epidermal growth factor receptor (EGFR) (homodimer of ErbB1) to induce downstream extracellular signal-regulated kinase 1 and 2 (ERK1/2) pathway signalling in the cumulus cells, as well as mRNA translation within the oocyte. The mechanism by which EGFR signalling promotes oocyte mRNA translation is yet to be elucidated. EGFR-ERK1/2 activity is essential for fertility as it regulates various events associated with ovulation. LH-induced NRG1 activates the ErbB3/2 heterodimeric receptor to regulate the timing of oocyte maturation and ovulation by reducing protein kinase C (PKC) pathway activity.
cells to the outer granulosa cell layers via gap junctions, causing the cGMP concentration throughout the follicle to become uniformly low (Egbert et al., 2014; Shuhaibar et al., 2015) . Low intra-oocyte cGMP leads to activation of the oocyte PDE3A, hydrolysis of cAMP, deactivation of PKA, and activation of MPF leading to oocyte meiotic resumption . AREG/EGFR signalling in the mouse decreases granulosa cell cGMP levels (Vaccari et al., 2009; Norris et al., 2010; Liu et al., 2014; Shuhaibar et al., 2015) by suppressing mRNA expression of Nppc, a gene encoding the C-type natriuretic peptide (CNP) that binds and activates NPR2 to induce cGMP synthesis (Tsuji et al., 2012) . Pharmacological inhibition of EGFR in explanted mouse antral follicles has been shown to perturb LH-induced cGMP downregulation (Norris et al., 2010) , however the extent to which EGFR signalling is required for this remains unclear; Norris et al. (2010) and Liu et al. (2014) demonstrate that EGFR activation mediates the lowering of cGMP by LH, however additional EGFR-independent pathways are also at play since the EGFR kinase inhibitor AG1478 only partially inhibits the cGMP decrease. This may be explained by the temporal kinetics of gap junction closure versus the spatiotemporal cGMP decrease in the follicle. Although EGFR ligands (AREG and EREG) promote gap junction closure of follicle-enclosed COCs through phosphorylation of connexins to perturb the flux of meiotic inhibitors cAMP and cGMP to the oocyte (Sela-Abramovich et al., 2005; Norris et al., 2008 Norris et al., , 2009 , cGMP diffusion out of the COC precedes this gap junction closure (Shuhaibar et al., 2015) . Hence, as well as a role in meiotic induction, the EGF network also plays a temporal role in the complex regulation of cGMP decay and thus removal of meiotic arresting signals.
Early evidence for the participation of EGF signalling in oocyte maturation came from in vitro studies. EGF induces oocyte maturation in explanted whole follicles (Dekel and Sherizly, 1985) and in isolated COCs meiotically arrested by cAMP modulators (Downs et al., 1988) . FSH-induced oocyte meiotic resumption and cumulus expansion in vitro is mediated by the EGF-like peptides (Shimada et al., 2006; Downs and Chen, 2008; Prochazka et al., 2011) . COC exposure to high levels of cAMP, a downstream effector of FSH, also induces meiotic resumption by upregulation of EGF-like peptides (Shimada et al., 2006; Downs and Chen, 2008) . Exogenous AREG, EREG, and EGF also induce meiotic resumption and cumulus expansion of COCs across a broad range of mammalian species, including human (Dekel and Sherizly, 1985; Das et al., 1992; Goud et al., 1998; Rieger et al., 1998; Shimada et al., 2006; Downs and Chen, 2008; Akaki et al., 2009; Ben-Ami et al., 2011; Prochazka et al., 2011; Richani et al., 2013) . Moreover, the co-culture of human follicular fluid (in which AREG was detected) with mouse COCs induced cumulus expansion and oocyte maturation; this effect was ablated when AREG was immuno-depleted (Zamah et al., 2010) . In the mouse, AREG-induced meiotic resumption in vitro was perturbed in the presence of the EGFR inhibitor AG1478 and EGFR antiserum in meiotically arrested COCs but not in oocytes stripped of their cumulus vestment prior to culture, indicating that the oocyte was not directly responsive to EGF-like peptides (Downs and Chen, 2008) . Collectively, these studies suggest that, apart from the clear effects of the ovulatory EGF network in curtailing the somatic cell supply of meiotic-inhibiting cGMP to the oocyte, activation of the EGF network in cumulus cells, whether indirectly by LH in vivo or by FSH and/or EGF-like peptides in vitro, leads to a series of events in cumulus cells that have powerful meiotic inducing actions in the oocyte (Downs et al., 1988) .
The EGF network contributes to oocyte developmental competence
The largest determinant of embryo developmental capacity and viability, and therefore the major limiting factor in female fertility, is oocyte developmental competence or oocyte quality. Developmental competence refers to the oocyte's capacity to mature, fertilize and ultimately yield viable offspring (Gilchrist and Thompson, 2007) . Much remains unknown about what consitutes oocyte developmental competence, despite the great clinical and commercial incentives to elucidate these processes, as such insights have the capacity to improve infertility treatment. Irrefutably, maternal health and the ovarian follicular environrment endows the oocyte with developmental competence. The maternal enviroment interfaces with the oocyte principally via an intricate bi-directional communication axis between the oocyte and follicular somatic cells, which fundamentally determines the oocyte's acquisition of developmental competence (Gilchrist et al., 2008; Gilchrist and Richani, 2013) . Paracrine release of oocytesecreted factors to regulate granulosa cell function, gap junctional transfer of regulatory molecules and metabolites, and somatic cell paracrine factors have all been shown to influence oocyte developmental competence (Gilchrist, 2011) . Given the obligatory role the EGF signalling network plays in the ovulatory cascade, one can expect it to play a central role in oocyte developmental competence.
In the human, AREG accumulates in the follicular fluid of ovulatory follicles following hCG stimulation of ART patients (Inoue et al., 2009; Zamah et al., 2010) . AREG levels in human follicular fluid are lower in follicles yielding immature germinal vesicle oocytes and those containing oocytes that exhibited aberrant embryo development (fertilization other than two pronuclei) (Zamah et al., 2010) . A recent study also demonstrated a positive correlation between LH-induced AREG mRNA expression in pooled human IVF granulosa and cumulus cells and subsequent IVF success parameters including number of oocytes retrieved and morphologically higher quality embryos (Huang et al., 2015) . Contrary to these studies, Inoue et al. (2009) reported a non-significant trend between higher AREG levels and decreased embryo quality and fertilization rate; however follicular fluid samples were pooled, preventing correlations with individual oocyte developmental outcomes. Proteomic analysis of follicular fluid from PCOS versus normo-ovulatory (male factor infertility) patients undergoing IVF revealed AREG to be significantly lower in PCOS patient follicular fluid (Ambekar et al., 2015) , which is hypothesized to result in decreased mucification of the cumulus matrix, thus contributing to the anovulation characteristic of this syndrome. Hence, there appears to be a strong link between the follicular accumulation of AREG and oocyte developmental competence. Studies to date have not detected EREG and BTC peptides in human follicular fluid or mouse COC conditioned media (Zamah et al., 2010; Richani et al., 2013) ; these growth factors have been reported to act in a juxtacrine fashion (Singh and Harris, 2005) , which may account for their absence when measuring secreted free ligands. In vitro, murine, bovine and porcine studies have also demonstrated that exposure to AREG and/or EREG enhances oocyte quality (see below) (Akaki et al., 2009; Prochazka et al., 2011; Richani et al., 2013 Richani et al., , 2014a Sugimura et al., 2014 Sugimura et al., , 2015 .
The EGF network may contribute to the regulation of oocyte integrity via regulation of oocyte programming during the meiotic maturation phase. The oocyte is transcriptionally silent following GVBD and relies on the translation of mRNA stores throughout maturation and into the early embryonic stage (Tan et al., 2009 ). The oocyte is dependent on cumulus cell signals that are mediated via the EGF network to regulate mRNA translation during maturation; in Areg null mice, which exhibit decreased fecundity, oocyte mRNA translation is significantly perturbed (Chen et al., 2013) . Moreover, FSH regulation of oocyte translation is mediated via EGFR (Franciosi et al., 2016) . Although the mechanisms involved in this relay from the cumulus cells to the oocyte are still emerging, the EGF network control of maternal mRNA translation is mediated by PI(3)K-AKTmTOR (phosphatidylinositol-4,5-bisphosphate 3-kinase-Protein kinase B-mechanistic target of rapamycin) signalling within the oocyte (Chen et al., 2013; Franciosi et al., 2016) . Taken together, human and animal studies demonstrate that the EGF network plays a major role in oocyte quality as assessed by the oocyte's capacity to support subsequent healthy embryo development.
EGF-like peptides impact COC metabolism
The effect of EGF-like peptides on COC energy metabolism may play a role in the increased oocyte development potential they endow on oocytes since COC metabolism is an important contributing factor to oocyte developmental competence (Krisher, 2004; Thompson et al., 2014) . In the mouse, exogenous EGF-like peptides and EGF increase intra-oocyte oxidative phosphorylation within the oocyte, and AREG and EREG induce significantly higher oocyte mitochondrial membrane potential than both FSH and EGF (Richani et al., 2014a,b) , which is suggestive of increased ATP production. In the cow, AREG enhances cumulus cell glycolysis compared with FSH (Sugimura et al., 2014) . Moreover, AREG increases oocyte NAD(P)H and FAD ++ levels in the presence of exogenous bone morphogenetic protein 15 (BMP15) through a gap junction mediated process (Sugimura et al., 2014) . In both in vivo and in vitro matured oocytes, ATP has been positively associated with subsequent developmental outcomes, such as meiotic spindle formation, fertilization rate and blastocyst development, in mammalian species including human (Stojkovic et al., 2001) . AREG and EREG also induce greater metabolic activity of the hexosamine biosynthesis pathway than FSH in mouse IVM COCs, enabling more hyaluronic acid synthesis, and consequently greater cumulus expansion (Richani et al., 2014a,b) , however this was not the case for cow COCs (Sugimura et al., 2014) . Proper cumulus matrix formation influences oocyte developmental competence; in vivo matured oocytes lacking an expanded cumulus oophorus have a poor capacity for subsequent implantation (Veeck, 1999) , and COCs matured in vitro with lower competence exhibit perturbed matrix formation with altered function compared to their in vivo counterparts (Dunning et al., 2012) . Cumulus cells cultured with AREG and EREG also exhibited greater global protein β-O-linked glycosylation (Richani et al., 2014a, b) . Increased global β-O-linked glycosylation has been associated with decreased IVM oocyte developmental competence in the mouse, pig, and cow (Sutton-McDowall et al., 2006; Pantaleon et al., 2010; Frank et al., 2014) . Target pathways of β-O-linked glycosylation which impact oocyte competence remain unclear, however glycosylation of the molecular chaperone heat shock protein 90 (HSP90) was shown to have a negative effect on oocyte competence in COCs matured in vitro and cultured under hyperglycaemic conditions (Frank et al., 2014) . Taken together, the evidence suggests that the EGF-like peptides regulate important aspects of glycolysis in cumulus cells and oxidative phosphorylation within the oocyte, which together are likely to contribute to their beneficial effects on oocyte developmental competence.
Acquisition of functional cumulus cell EGF network signalling is an oocyte developmental milestone
An important concept to emerge in recent years is the notion that the acquisition of functional signalling of the EGF network in cumulus cells is tightly developmentally regulated. COCs from small antral follicles are inherently unresponsive to the full range of EGF family ligands, and COCs progressively acquire EGF responsiveness with advancing folliculogenesis (Prochazka et al., 2000 (Prochazka et al., , 2003 Diaz et al., 2007; Ritter et al., 2015) . This is consistent with the central role of the peri-ovulatory cascade of EGF-like peptides as core transducers of oocyte maturation and ovulation. Not only must the COC in the single Graffian follicle (mono-ovular species) be capable of responding to the ovulatory surge of EGF peptides in order to be ovulated, but all COCs in subordinate antral follicles must not be capable of responding . Limiting cumulus cell EGF responsiveness to the Graffian follicle may be a basic physiological mechanism of restricting ovulation to a single follicle (Fig. 3) . The acquisition of EGF signalling capability by cumulus cells with progressive follicle size coincides with oocyte acquisition of developmental competence, and the two processes are likely inter-related Sugimura et al., 2015) . It is well known that throughout the course of the antral stage of folliculogenesis, oocytes progressively acquire the capacity to support ever-advancing stages of embryo and foetal development (Eppig et al., 1992; Lonergan et al., 1994) . This concept serves as the foundation for the need to superovulate women during IVF in order to generate preovulatory sized follicles that contain developmentally competent oocytes (Fig. 3) . The cellular and molecular mechanisms by which cumulus cells acquire EGF signalling capabilities with follicle development is an important issue; we hypothesized that this is likely to represent a milestone in oocyte development as it likely plays a role in oocyte competence. EGFR mRNA, and commonly the protein, are expressed on all sub-types of granulosa cells (preantral and mural granulosa cells, and cumulus cells) throughout the full course of follicle development, as a range of EGF family members have growthpromoting actions during the early stages (Roy, 1993; Garnett et al., 2002) . Prochazka et al. (2003) hypothesized that the EGFR in COCs from small antral follicles is under-developed in some manner. A number of studies have found that EGFR mRNA levels are lower in cumulus cells from small antral follicles compared to those from large antral follicles (Singh et al., 1995; Prochazka et al., 2003; Caixeta et al., 2009; El-Hayek et al., 2014) . By contrast, we observed that cumulus cells from small antral follicles express EGFR transcripts to the same extent as their larger antral counterparts, however they lack protein translation and phosphorylation and, consequently, lack downstream ERK1/2 activity. As such, COCs from small antral follicles lack the ability to respond to EGF and undergo cumulus expansion. Hence, there is consensus in the literature that the EGF signalling network is under-developed in COCs from small antral follicles.
Cumulus cell receptivity to EGF-like peptides requires both endocrine and oocyte paracrine cues How do cumulus cells acquire EGF signalling functionality as they advance towards ovulation? Many of the specific details of the mechanisms regulating the maturation of cumulus cell EGFR signalling are lacking, however it has become clear that both endocrine and oocyte paracrine signals are required. Evidence implicates FSH as a key regulator in the development of a functional EGF network during follicle development. Exposure to FSH in vitro alters the preantral granulosa-to-cumulus cell transition such that these cells respond to gonadotrophic cues for cumulus expansion, including acquisition of cumulus cell EGF functionality (Diaz et al., 2007) . In vivo, Fshb −/− mice are unable to form large antra and exhibit perturbed follicle Egfr mRNA expression, oocyte meiotic progression and cumulus cell differentiation, all of which can be recovered when follicles are exposed to exogenous FSH (El-Hayek et al., 2014) . Moreover, exposure of porcine COCs from small antral follicles to exogenous FSH promotes EGF-induced EGFR signalling (Prochazka et al., 2003) . PKA signalling, which is a downstream effector of FSH-cAMP, is also required for AREG to induce cumulus cell expansion (Prochazka et al., 2012) . Together, these studies suggest that endocrine cues are essential for development of the EGF signalling network in cumulus cells, and that this process is principally mediated by FSH-cAMP-PKA messages. However, it seems that this endocrine message alone is insufficient, and that co-operation, at the cumulus cell level, between FSH signalling and oocyte paracrine signals is required to elicit full EGF functionality in cumulus cells (Fig. 4) . The differentiation of preantral granulosa cells to cumulus cells during the preantral-to-antral follicle transition is dependent on oocyte cues. Prior to differentiation into cumulus cells, preantral granulosa cells are unable to undergo expansion. Diaz et al. (2006 Diaz et al. ( , 2007 demonstrated that this is partly because the secretome of the growing preantral oocyte lacks essential cues to promote expansion. Coculture of preantral granulosa cells with fully grown oocytes, in Graffian follicles (e.g. early follicular phase or luteal phase). Cumulus-oocyte complexes (COCs) from small antral follicles are inherently unresponsive to the full range of EGF family ligands since they lack a functional EGFR (unresponsive cumulus cells depicted as purple). (B) An unstimulated preovulatory ovary containing one Graffian follicle. As folliculognesis proceeds towards ovulation under the influence of FSH and LH, the EGFR on cumulus cells undergoes functional changes such that only the COC in the Graffian follicle acquires EGF peptide family responsiveness (depicted as red cumulus cells). Limiting cumulus cell EGF responsiveness to the Graffian follicle may be a basic physiological mechanism of restricting ovulation to a single follicle. This is associated with a concomitant acquisition of developmental competence by the oocyte. The COC attaining EGF peptide responsiveness is likely to represent a key developmental checkpoint in folliculogenesis and a milestone in the acquisition of oocyte developmental competence. (C) A superovulated ovary. The growth of multiple follicles to preovulatory size under the influence of exogenous FSH leads to simultaneous induction of EGFR functionality and acquisition of developmental competence in multiple COCs.
concert with prior FSH priming, enabled these cells to acquire full cumulus expansion capability (in response to EGF), which is a hallmark of cumulus cell differentiation. Sugimura et al. (2015) recently demonstrated that small antral porcine COCs become AREG-responsive in the presence of cAMP, however this required oocyte participation through the actions of the oocyte-secreted factors BMP15 and/or growth differentiation factor 9 (GDF9). Cyclic AMP had little effect on AREG-induced meiotic maturation, cumulus expansion, ERK1/2 phosphorylation and blastocyst development in small antral oocytes in the absence of BMP15 and GDF9 . This is consistent with the finding that mouse oocytes mediate cumulus cell EGFR expression via GDF9 and BMP15 mediated activation of Sma-and Mad-related protein (SMAD)2/3 . In addition, cross-talk between EGFR-ERK1/2 and SMAD2/3 signalling in granulosa and cumulus cells also appears important to elicit full GDF9 activity . EGF responsiveness can be induced in cumulus cells from small antral follicles by native factors secreted from developmentally competent oocytes of mid-sized antral follicles . The same effect cannot be elicited by native oocyte-secreted factors from low competence oocytes of small antral follicles, demonstrating that cumulus cell acquisition of EGFR signalling is a developmental hallmark for the COC . Hence, by modulating its secretome throughout folliculogenesis, the oocyte controls the responsiveness of its support somatic cells to EGF-like peptides. This mechanism prevents premature activation of the EGFR network in the presence of the waves of pituitary gonadotrophin secretion during successive menstrual cycles, preventing meiotic resumption and ovulation until folliculogenesis is complete and the oocyte reaches full competence (Fig. 4) . In this sense, dual FSH-and oocyte-induction of EGF responsiveness in cumulus cells represents a developmental hallmark in folliculogenesis, analogous to the FSH-induction of LH receptor signalling that is a hallmark of mural granulosa cell development .
EGF signalling is perturbed by IVM
The status of the EGF signalling network has important implications for the practical application of oocyte IVM to treat infertility. IVM is a reproductive technology that generates mature oocytes by culturing immature intact COCs for 24-28 h (Edwards, 1965) . IVM is an attractive approach as patients receive minimal or no prior FSH stimulation and, according to the existing definition, no hCG stimulation (De Vos et al., 2016) . The IVM approach is particularly relevant to women with PCOS and has important applications in fertility preservation for young women and girls diagnosed with cancer . IVM is widely practiced in domestic animal artificial breeding, particularly in cattle, but is less commonly practiced in human ART. The principle reason for its poor uptake in human ART is the lower pregnancy rates compared to IVF and not because of safety concerns Kuhtz et al., 2014; Spits et al., 2015) . It is notable however, that typical existing IVM methodologies were designed prior to our new appreciation of the importance of the EGF network for oocyte maturation and quality. Hence, incorporating factors/processes into IVM that capitalize on a functional EGF network will bring opportunities to improve the efficiency and therefore the uptake of IVM (Gilchrist, 2011) .
Several studies have demonstrated a deficiency in cumulus cell EGF-like peptide expression in COCs matured by IVM, compared with COCs matured in vivo. Cumulus cell Areg, Ereg, and Btc mRNA expression and AREG protein secretion is perturbed throughout FSH-induced IVM relative to in vivo matured mouse COCs (Richani et al., , 2014a . AREG mRNA expression at the end of FSHinduced IVM is also significantly lower than that seen after in vivo oocyte maturation in human cumulus cells from ≤6 mm antral follicles (Guzman et al., 2012 (Guzman et al., , 2013 . In addition, global mRNA microarray analysis of mouse COC demonstrated decreased expression of the Figure 4 Hypothesized mechanism of co-operation between endocrine cues and oocyte paracrine signals to promote cumulus cell EGFR functionality. Cumulus cells of small antral follicles have a poor capacity for EGFR signalling as they are unresponsive to EGF-like peptides. Oocytes from these follicles also have poor developmental capacity. As folliculogenesis progresses, cumulus cells acquire EGFR functionality through crosstalk between the oocyte (via the actions of oocyte-secreted factors, at least growth differentiation factor 9 (GDF9) and bone morphogenetic protein 15 (BMP15)) and FSH-induced cyclic adenosine monophosphate (cAMP) signalling, and is associated with increased oocyte developmental competence. three EGF-like peptides in FSH-induced mouse IVM cumulus cells relative to their in vivo matured counterparts, and genes for the three peptides were among the most differentially expressed between the two COC types (Kind et al., 2013) . A large source of follicular EGFlike peptides following the LH stimulus is the mural granulosa cells (Park et al., 2004) as they are the major epithelial component of the follicle. One of the earliest signals the COC receives to resume maturation and prepare for embryonic development is from EGF-like peptides produced by mural granulosa cells, leading to autoamplification of this signalling network in cumulus cells (Shimada et al., 2006) . Hence, IVM COCs are likely to be deficient in receiving the ovulatory message via the EGF network at multiple levels; they do not receive direct ligand activation of their EGFRs as a consequence of the absence of mural granulosa cell derived EGF-like peptides; as a consequence of this, cumulus cells do not receive the normal ERK1/2-PGE2-p38MAPK auto-amplification signal, leading to truncated autocrine production of EGF-like peptides; and IVM COCs are usually derived from smaller, growing antral follicles in which the cumulus cell EGF network is still developing (see previous section). Many of these deficiencies are, at least in part, overcome by the use of FSH in IVM media. Nonetheless, it might be expected that supplementation of IVM media with EGF-like peptides will be beneficial for IVM outcomes.
IVM with exogenous EGF-like peptides improve oocyte quality
Given that full activation of the EGF network is typically deficient in IVM, a number of studies have examined the effect of exogenous supplementation during oocyte maturation in vitro (Table II) . In the mouse, EREG significantly increases blastocyst yield compared to FSH or EGF, and both EREG and AREG significantly increase the blastocyst inner cell mass (ICM) . Although developmental parameters following the pre-implantation period have not been examined, small increases in ICM cell number are known to translate into large increases in mouse foetal yield (Albuz et al., 2010; Sudiman et al., 2014) . Prochazka et al. (2011) also reported a significant increase in porcine embryo yield and size from parthenogenetically activated IVM COCs matured with AREG or EREG compared with FSH or LH, despite a lower percentage of oocytes reaching metaphase II. These data suggest that bioactive EGF-like peptides may be more suitable IVM additives than FSH, or indeed other members of the EGF family. The molecular basis for this remains unclear, however given that FSH and EGF are not the physiological inducers of oocyte maturation in vivo, an IVM system utilizing EGF-like peptides likely represents a more physiological form of IVM that recreates an environment more closely resembling that found in vivo. This is supported by the observation that in the mouse AREG and EREG (but not BTC) stimulate comparable expression of EGF-like peptide mRNA to cumulus cells in vivo, whereas FSH is a relatively poor stimulator of peptide expression . Moreover, the gene transcription profiles of cumulus cells stimulated with FSH versus AREG/EREG in vitro differ significantly (Blaha et al., 2015) . Ligand availability does not solely account for the increased developmental competence endowed by the EGF-like peptides in IVM since EGF is equally potent at promoting EGF-like peptide mRNA expression and yet yields oocytes with lower developmental potential (Richani et al., , 2014a . Additionally, EGF does not elicit the same level of COC EGFR phosphorylation at Tyr 1068 as AREG or EREG (Richani et al., 2014a,b) , which may be a difference in ligand-receptor interaction affecting signal duration and EGFR trafficking (see earlier). EGF also promotes lower oocyte mitochondrial activity than the EGF-like peptides (Richani et al., 2014a,b very similar fashion, can induce distinct biological responses in cumulus cells and highlight the importance of elucidating optimal peptide combinations and temporal kinetics to yield the greatest improvement in oocyte quality in vitro. In-depth evaluation of EGF-like peptide dose responses, peptide combinations, and data on foetal outcomes are lacking, however healthy porcine offspring have been produced using a bi-phasic IVM system devoid of gonadotrophins that used AREG with EGF and dibutyryl cAMP (Akaki et al., 2009 ). Species differences in EGF-like peptide involvement likely exist since studies indicate EREG to be the most suitable EGF-like peptide for use in mouse IVM as it yields the best developmental and metabolic outcomes (Richani et al., , 2014a , whereas AREG seems suitable for human IVM as only AREG was detectable in the follicular fluid of women following ovarian hyperstimulation (Zamah et al., 2010) , and showed positive correlation of mRNA expression with IVF outcomes (Huang et al., 2015) . Collectively, the animal literature demonstrates that addition of exogenous EGF-like peptides, instead of the commonly used additive FSH, to IVM culture systems improves blastocyst development (Table II) (Akaki et al., 2009; Prochazka et al., 2011; Richani et al., 2013; Sugimura et al., 2015) , hence this concept warrants investigation in human IVM.
The underdeveloped EGF network within COCs from small antral follicles poses an obstacle to using the EGF-like peptides in human and animal IVM since oocytes are typically retrieved from small to mid-sized antral follicles (Guzman et al., 2012 (Guzman et al., , 2013 . Fortunately, the recent insights into means to induce EGFR functionality in these COCs by exposure to cAMP and oocyte-secreted factors (see above) provides new opportunities for improving IVM (Gilchrist, 2011) . A key component to inducing EGFR functionality is prevention of precocious meiotic resumption upon COC isolation from the follicle using cAMP modulators, which can be achieved using a phosphodiesterase (PDE) inhibitor in the IVM phase, or a short (1-4 h) pre-IVM phase using high levels of cAMP, or using cAMP modulators in the first half of a bi-phasic IVM system (recently reviewed, ). All these approaches preserve gap junctional communication between the cumulus cells and the oocyte. By treating COCs from small antral follicles with cAMP modulators together with GDF9 and/or BMP15, these COCs acquire EGF peptide responsiveness , such that upon AREG stimulation they exhibit greater ERK1/2 activation and higher developmental competence than when matured with FSH . Similarly, combined use of cAMP, cumulin (a GDF9: BMP15 heterodimer described by Mottershead et al. (2015) ) and AREG led to notable improvements in embryo yield from low competence porcine oocytes . A significant new advance using a similar approach, is the use of C-type natruiretic peptide and GDF9 in a bi-phasic IVM system to induce AREG responsiveness and developmental competence in COCs derived from peri-antral follicles from unstimulated mice (Romero et al., 2016) .
Conclusion
It is now clear that the EGF network is a key player in the ovulatory cascade as it transmits the LH signal from the periphery of the follicle to the oocyte. In addition to providing stimulatory signals, recent insight has demonstrated that the EGF cascade downregulates signals (cGMP) that suppress oocyte maturation in the preovulatory follicle. The EGF signal also controls oocyte cytoplasmic maturation (including regulation of mRNA translation in the maturing oocyte), a process integral for oocyte developmental competence. Oocyte quality is a cornerstone of fertility potential. Recent insights show that development of a functional EGF network, specifically in cumulus cells as the follicle approaches ovulation, plays a role in the acquisition of a developmentally competent oocyte. This knowledge is important in the context of superovulation, as it appears that it induces an effective EGF signalling network in the multiple follicles recruited and the COCs therein, although whether the EGF network is deficient in some manner following superovulation, thereby impacting oocyte quality, remains to be determined. Such insights have already led to advances in oocyte IVM in animal models where the addition of exogenous EGF-like peptides improves embryo outcomes. Such an approach may represent a more physiological IVM system as it likely mimics key in vivo signalling events more closely than current approaches. Clinical use of EGF-like peptides has the potential to increase the success rate of IVM, making it a viable and more attractive treatment option for a wide range of patients, including those with cancer or PCOS, and those with financial restrictions.
